Tango Therapeutics, Inc. is a biopharmaceutical company that specialises in developing precision medicines to improve patient outcomes in cancer. Its operation primarily covers the United States, focusing on leveraging the body's immune system to combat disease.
The company is part of the biotechnology industry, known for its advancements in medical solutions. Tango Therapeutics, Inc. aims to deliver the next generation of precision medicine for the treatment of cancer by targeting genetic vulnerabilities in cancer cells and using its proprietary suite of drug discovery tools to find unique therapeutic opportunities.
Diversify your virtual portfolio by following TNGX shares on eToro.